12264 related articles for article (PubMed ID: 11668469)
61. HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas.
Yu CH; Chen HH; Liu CM; Jeng YM; Wang JT; Wang YP; Liu BY; Sun A; Chiang CP
J Oral Pathol Med; 2005 Oct; 34(9):540-5. PubMed ID: 16138892
[TBL] [Abstract][Full Text] [Related]
62. Melanocytic differentiation is present in a significant proportion of nonpigmented diffuse neurofibromas: a potential diagnostic pitfall.
Pižem J; Nicholson KM; Mraz J; Prieto VG
Am J Surg Pathol; 2013 Aug; 37(8):1182-91. PubMed ID: 23715161
[TBL] [Abstract][Full Text] [Related]
63. Metastatic melanoma to the vagina: clinicopathologic and immunohistochemical study of three cases and literature review.
Gupta D; Neto AG; Deavers MT; Silva EG; Malpica A
Int J Gynecol Pathol; 2003 Apr; 22(2):136-40. PubMed ID: 12649667
[TBL] [Abstract][Full Text] [Related]
64. Micropthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma.
Salti GI; Manougian T; Farolan M; Shilkaitis A; Majumdar D; Das Gupta TK
Cancer Res; 2000 Sep; 60(18):5012-6. PubMed ID: 11016620
[TBL] [Abstract][Full Text] [Related]
65. Microphthalmia-associated transcription factor (MiTF): Promiscuous staining patterns in fibrohistiocytic lesions is a potential pitfall.
Mohanty SK; Sharma S; Pradhan D; Kandukuri SR; Farahani N; Barry C; Wu JM; Frishberg D; Balzer B
Pathol Res Pract; 2018 Jun; 214(6):821-825. PubMed ID: 29773427
[TBL] [Abstract][Full Text] [Related]
66. Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA.
Sundram U; Harvell JD; Rouse RV; Natkunam Y
Mod Pathol; 2003 Aug; 16(8):802-10. PubMed ID: 12920225
[TBL] [Abstract][Full Text] [Related]
67. MITF positivity in atypical fibroxanthoma: a diagnostic pitfall.
Tallon B; Beer TW
Am J Dermatopathol; 2014 Nov; 36(11):888-91. PubMed ID: 25238448
[TBL] [Abstract][Full Text] [Related]
68. Immunohistochemical analysis of benign and malignant melanocytic lesions of the conjunctiva using double-staining.
Soon AK; Brownstein S; Tang T; Saleh S; Jiang K; Levac J; Blanco P; Farmer J
Can J Ophthalmol; 2019 Dec; 54(6):699-707. PubMed ID: 31836103
[TBL] [Abstract][Full Text] [Related]
69. Immunohistochemical studies of conjunctival nevi and melanomas.
Jakobiec FA; Bhat P; Colby KA
Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539
[TBL] [Abstract][Full Text] [Related]
70. Immunohistochemical expression of S-100 beta in choroidal melanomas.
Martins MC; Scull JJ; Alcocer CE; Deschênes J; Antecka E; Burnier MN
Can J Ophthalmol; 1997 Oct; 32(6):378-81. PubMed ID: 9363341
[TBL] [Abstract][Full Text] [Related]
71. Primary cutaneous PEComa: distinctive clear cell lesions of skin.
Liegl B; Hornick JL; Fletcher CD
Am J Surg Pathol; 2008 Apr; 32(4):608-14. PubMed ID: 18277881
[TBL] [Abstract][Full Text] [Related]
72. Immunophenotype of conjunctival melanomas: comparisons with uveal and cutaneous melanomas.
Iwamoto S; Burrows RC; Grossniklaus HE; Orcutt J; Kalina RE; Boehm M; Bothwell MA; Schmidt R
Arch Ophthalmol; 2002 Dec; 120(12):1625-9. PubMed ID: 12470134
[TBL] [Abstract][Full Text] [Related]
73. P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma.
Lazova R; Tantcheva-Poor I; Sigal AC
J Am Acad Dermatol; 2010 Nov; 63(5):852-8. PubMed ID: 20950740
[TBL] [Abstract][Full Text] [Related]
74. PNL2 melanocytic marker in immunohistochemical evaluation of primary mucosal melanoma of the head and neck.
Morris LG; Wen YH; Nonaka D; DeLacure MD; Kutler DI; Huan Y; Wang BY
Head Neck; 2008 Jun; 30(6):771-5. PubMed ID: 18228523
[TBL] [Abstract][Full Text] [Related]
75. Kba.62 and S100 protein expression in cytologic samples of metastatic malignant melanoma.
Erdag G; Chowdhuri SR; Fetsch P; Erickson D; Hughes MS; Filie AC
Diagn Cytopathol; 2013 Oct; 41(10):847-51. PubMed ID: 23554410
[TBL] [Abstract][Full Text] [Related]
76. [Monoclonal antibody HMB-45 in diagnosis of intra-ocular melanoma].
Rohrbach JM; Steuhl KP; Thanos S
Klin Monbl Augenheilkd; 1991 Oct; 199(4):274-7. PubMed ID: 1762354
[TBL] [Abstract][Full Text] [Related]
77. Melanoma-associated antigen recognized by T cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration.
Fetsch PA; Marincola FM; Filie A; Hijazi YM; Kleiner DE; Abati A
Cancer; 1999 Feb; 87(1):37-42. PubMed ID: 10096358
[TBL] [Abstract][Full Text] [Related]
78. SOX10: a useful marker for identifying metastatic melanoma in sentinel lymph nodes.
Willis BC; Johnson G; Wang J; Cohen C
Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):109-12. PubMed ID: 25356946
[TBL] [Abstract][Full Text] [Related]
79. Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful?
Karimipour DJ; Lowe L; Su L; Hamilton T; Sondak V; Johnson TM; Fullen D
J Am Acad Dermatol; 2004 May; 50(5):759-64. PubMed ID: 15097961
[TBL] [Abstract][Full Text] [Related]
80. Rapid frozen section immunostaining of melanocytes by microphthalmia-associated transcription factor.
Glass LF; Raziano RM; Clark GS; Higgins HW; Ladd S; Lien MH; Chen R; Cherpelis BS
Am J Dermatopathol; 2010 Jun; 32(4):319-25. PubMed ID: 20514666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
